Synergy between sacubitril and valsartan leads to hemodynamic, antifibrotic, and exercise tolerance benefits in rats with preexisting heart failure
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synergy between sacubitril and valsartan leads to hemodynamic, antifibrotic, and exercise tolerance benefits in rats with preexisting heart failure
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
Volume 316, Issue 2, Pages H289-H297
Publisher
American Physiological Society
Online
2018-11-21
DOI
10.1152/ajpheart.00579.2018
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sacubitril/valsartan and short-term changes in the 6-minute walk test: A pilot study
- (2018) Paola Beltrán et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Neprilysin inhibition in heart failure: mechanisms and substrates beyond modulating natriuretic peptides
- (2017) Emilia D'Elia et al. EUROPEAN JOURNAL OF HEART FAILURE
- Papel del colágeno miocárdico en la estenosis aórtica grave con fracción de eyección conservada y síntomas de insuficiencia cardiaca
- (2017) Kattalin Echegaray et al. REVISTA ESPANOLA DE CARDIOLOGIA
- Female rats with severe left ventricle volume overload exhibit more cardiac hypertrophy but fewer myocardial transcriptional changes than males
- (2017) Catherine Beaumont et al. Scientific Reports
- Exercise capacity and peak oxygen consumption in asymptomatic patients with chronic aortic regurgitation
- (2016) Kaspar Broch et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Efficacy and Safety of 1-Hour Infusion of Recombinant Human Atrial Natriuretic Peptide in Patients With Acute Decompensated Heart Failure
- (2016) Guogan Wang et al. MEDICINE
- Efficacy of Sacubitril/Valsartan Relative to a Prior Decompensation
- (2016) Scott D. Solomon et al. JACC-Heart Failure
- Valsartan-induced cardioprotection involves angiotensin II type 2 receptor upregulation in isolated ischaemia and reperfused rat hearts
- (2015) Ke-yan Li et al. ACTA CARDIOLOGICA
- Heart Disease and Stroke Statistics—2016 Update
- (2015) Dariush Mozaffarian et al. CIRCULATION
- Angiotensin II can directly induce mitochondrial dysfunction, decrease oxidative fibre number and induce atrophy in mouse hindlimb skeletal muscle
- (2015) Tomoyasu Kadoguchi et al. EXPERIMENTAL PHYSIOLOGY
- Controlled release metoprolol for aortic regurgitation: a randomised clinical trial
- (2015) Kaspar Broch et al. HEART
- Vascular Dilation, Tachycardia, and Increased Inotropy Occur Sequentially with Increasing Epinephrine Dose Rate, Plasma and Myocardial Concentrations, and cAMP
- (2015) Mikhail Y. Maslov et al. Heart Lung and Circulation
- Novel mechanism of cardiac protection by valsartan: synergetic roles of TGF-β1 and HIF-1α in Ang II-mediated fibrosis after myocardial infarction
- (2015) Xizhong Sui et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Transcriptional Changes Associated with Long-Term Left Ventricle Volume Overload in Rats: Impact on Enzymes Related to Myocardial Energy Metabolism
- (2015) Elise Roussel et al. Biomed Research International
- Natriuretic Peptides in the Regulation of Cardiovascular Physiology and Metabolic Events
- (2015) Risto Kerkelä et al. Journal of the American Heart Association
- Sildenafil treatment attenuates ventricular remodeling in an experimental model of aortic regurgitation
- (2015) Kristian Eskesen et al. SpringerPlus
- Use of Pressure-volume Conductance Catheters in Real-time Cardiovascular Experimentation
- (2014) Abraham E. Wei et al. Heart Lung and Circulation
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
- (2014) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Direct regulation of ENaC by bradykinin in the distal nephron. Implications for renal sodium handling
- (2013) Mykola Mamenko et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- High concentrations of drug in target tissues following local controlled release are utilized for both drug distribution and biologic effect: An example with epicardial inotropic drug delivery
- (2013) Mikhail Y. Maslov et al. JOURNAL OF CONTROLLED RELEASE
- Atrial natriuretic peptide exerts protective action against angiotensin II-induced cardiac remodeling by attenuating inflammation via endothelin-1/endothelin receptor A cascade
- (2012) Shuichi Fujita et al. HEART AND VESSELS
- Local epicardial inotropic drug delivery allows targeted pharmacologic intervention with preservation of myocardial loading conditions
- (2011) Mark A. Lovich et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Diastolic Tissue Doppler Indexes Correlate With the Degree of Collagen Expression and Cross-Linking in Heart Failure and Normal Ejection Fraction
- (2011) Mario Kasner et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Valsartan Improves Endothelial Dysfunction in Hypertension: A Randomized, Double-Blind Study
- (2009) Nikolaos Tzemos et al. Cardiovascular Therapeutics
- Measurement of cardiac function using pressure–volume conductance catheter technique in mice and rats
- (2008) Pál Pacher et al. Nature Protocols
- Atrial Natriuretic Peptide Inhibits Transforming Growth Factor β–Induced Smad Signaling and Myofibroblast Transformation in Mouse Cardiac Fibroblasts
- (2007) Peng Li et al. CIRCULATION RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now